FCA Whistleblowers Accuse Gilead Of Defective-Drug Fraud
By Jeff Overley · September 11, 2014, 3:06 PM EDT
Gilead Sciences Inc. cheated taxpayers by selling contaminated and defective drugs to Medicare and Medicaid, whistleblowers charged in a False Claims Act lawsuit unsealed Wednesday in California federal court, adding to...
To view the full article, register now.